AQST Q2 2022 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AQSTAquestive Therapeutics, Inc.

$431M

Q2 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$13M-13.6% YoY

Gross Profit

$8M60.5% margin

Operating Income

-$13M-96.2% margin

Net Income

-$16M-122.9% margin

EPS (Diluted)

$-0.44

QoQ Revenue Growth

+8.1%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$56M

Total Liabilities

$153M

Stockholders' Equity

-$96M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$15M	-13.6%
Gross Profit	$8M	$11M	-26.3%
Operating Income	-$13M	-$7M	-95.8%
Net Income	-$16M	-$12M	-31.8%

Revenue Segments

Manufacture and Supply Revenue

$10M74%

Proprietary Product Sales

$3M20%

License and Royalty Revenue

$552,0004%

Co-Development and Research Fees

$241,0002%

Geographic Segments

UNITED STATES

$11M85%

Non-US

$2M15%